Peak XV raises Surge seed investment ceiling to $5M with 18-startup cohort

Peak XV Partners is increasing the maximum investment available through its Surge seed platform from $3 million to $5 million per startup, as the venture firm introduces an 18-company cohort built increasingly for international markets.

The new batch, Surge 12, received more than $50 million in total from Peak XV, according to the firm. The startups have collectively raised more than $90 million in seed funding, while at least three had secured outside capital before joining the program. The move reflects a seed market in which companies—particularly those building deep-tech products—may need more capital before they can demonstrate the traction required for a Series A.

A larger check at a more demanding stage

Rajan Anandan, Peak XV’s managing director, told TechCrunch that the threshold for raising a Series A has risen significantly. He also pointed to a growing number of capital-intensive companies entering the market, especially in deep tech, where hardware, research, regulatory work, and specialized talent can extend the path from prototype to commercial product.

Surge’s new ceiling does not mean every startup receives $5 million. Peak XV said its median investment per company has increased but did not disclose the figure. The firm’s stated total of more than $50 million across 18 startups indicates that individual allocations vary substantially.

The change also positions Surge as more than a conventional accelerator-style program. Peak XV describes it as its primary route for seed-stage investing and says it typically remains involved as companies move into later rounds. Since the platform launched in 2019, when the firm operated as Sequoia Capital India and Southeast Asia, it says Surge has backed more than 180 startups founded by entrepreneurs from over 18 nationalities.

The cohort is built in India but aimed beyond it

Surge 12 includes founders and companies spread from San Francisco to Sydney. More than half of the startups are based in India, but only five are focused primarily on the Indian market. The other 13 are targeting global customers, highlighting a distinction that is becoming more important for regional venture investors: where a startup is built is not necessarily where it expects to sell.

The group covers AI, robotics, space, healthcare, consumer products, music, and financial services. Its AI-related companies include Hiloop, which is developing a post-training platform to help companies adapt open-weight models for specific applications; Reinforce Labs, which is building tools to evaluate, red-team, and remediate enterprise AI systems; and Kindling, which is applying AI to communications and content production for technology startups.

Other companies illustrate the breadth of the cohort. Alma is developing a personal computing platform and was founded by former Microsoft Research and Sarvam AI engineers. Puralink is working on autonomous robots for underground pipe networks, while Ulook is developing satellite systems for radio-frequency sensing and spectrum intelligence.

The cohort also includes August AI, a healthcare platform combining AI with physician-led care; Rosella, an AI-native commercial insurance brokerage for U.S. businesses; Kello, an AI-assisted talent-discovery platform; and Tribe Money, a personal-finance product for tracking money, researching investments, and supporting financial decisions.

Three startups have not yet been publicly identified. Peak XV said they operate in education, applied AI, and medical products.

Evidence behind Peak XV’s claims

The financial figures and portfolio statistics in this story come from Peak XV, as reported by TechCrunch. They are therefore vendor-reported figures rather than independently audited measures. The firm said the Surge 12 companies had raised more than $90 million collectively and that its ten largest Surge companies now generate more than $1 billion in combined annual revenue. Peak XV did not provide company-by-company revenue data or explain how the largest companies were selected.

Several startups had already attracted funding before joining the cohort. Ditto had raised $9.2 million in a Peak XV-led seed round, according to the report. Rosella had raised about $2.5 million in a pre-seed round led by Peak XV and Intact Private Capital, while Ulook had secured roughly $2.3 million from growX Ventures and InfoEdge Ventures.

Those examples suggest that Surge is not limited to companies at the earliest idea or prototype stage. However, the available reporting does not establish how much of the cohort had meaningful revenue, production deployments, or repeatable customer demand at entry. The higher ceiling should be read as a capacity to invest, not evidence that every company has reached product-market fit.

What the move means for builders and buyers

For AI founders, the expanded ceiling could reduce the need to raise another round immediately after an initial seed financing. That matters for companies developing model infrastructure, safety tooling, robotics, or other products with substantial research and operating costs. More runway can support hiring, evaluation, hardware iteration, and early enterprise deployments before the company must return to the market.

The tradeoff is a higher expectation that larger seed rounds produce measurable progress. If Series A investors are demanding stronger evidence, founders may need to show more than a compelling demo: production usage, durable customer contracts, reliable model performance, or a credible route to gross-margin improvement. Capital alone will not resolve the technical and distribution risks facing applied AI companies.

Enterprise buyers may also find more early-stage vendors offering specialized AI products, including tools for model adaptation, AI assurance, insurance operations, healthcare delivery, and talent assessment. These buyers will need to examine security, data governance, evaluation methods, service continuity, and the financial backing behind young suppliers. A larger seed check can extend a company’s runway, but it does not remove the risk associated with adopting an unproven platform.

For Peak XV, the cohort represents a broader geographic and sector strategy. Its India presence remains central, but the firm is backing startups that may sell primarily in the United States or other international markets. That approach could increase the addressable market for its portfolio while also exposing founders to more competitive sales environments and higher expectations from global customers.

What to watch next

The clearest follow-up signal will be whether Surge 12 companies convert the new capital into later-stage financing. Series A announcements, disclosed lead investors, and the size and timing of those rounds will show whether the larger seed ceiling is helping companies cross the market’s higher funding bar.

Customer evidence will matter as well. Watch for production deployments, enterprise renewals, revenue disclosures, and measurable outcomes from companies such as Hiloop, Reinforce Labs, Rosella, and Ulook. For robotics and space startups, technical milestones and commercial contracts may be more informative than conventional software growth metrics.

Investors and founders should also watch whether Peak XV raises the ceiling again, changes the structure of Surge, or concentrates more capital in deep-tech and AI infrastructure. The firm’s next cohorts will indicate whether Surge 12 is a one-off response to capital intensity or part of a durable shift in seed-stage strategy.

Creati.ai perspective

Peak XV’s decision is significant less because of the headline $5 million figure than because it confirms how the seed market is changing for technically ambitious startups. Companies building AI systems, robotics, and space hardware may need meaningful capital before their products can generate the evidence later-stage investors expect.

The important test will be discipline. A larger seed investment should buy time to prove reliability, customer value, and a scalable business—not simply postpone difficult questions about demand. Surge 12 will be worth tracking as a case study in whether more early capital can help global startups reach Series A readiness without inflating the gap between funding and commercial validation.